Epzicom and haemoglobin decreased Patient Reports February 11, 2012

Epzicom Side Effects Report #5865147-1
Epzicom side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2008. Male patient, 49 years of age, was diagnosed with hiv infection  and was treated with Epzicom. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood bilirubin increased, c-reactive protein increased, fatigue, haemoglobin decreased, hypersensitivity, lethargy. Epzicom dosage: unknown. During the same period patient was treated with NORVIR, REYATAZ, BACTRIM, JANUVIA, ACTOS, ANTARA, SYMBICORT, XOPENEX. Patient recovered.

Epzicom Side Effects Report #5459505-7
Epzicom side effect was reported by a Physician from JAPAN on Sept 14, 2007. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome, antifungal prophylaxis, syphilis  and was treated with Epzicom. After drug was administered, patient experienced the following side effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder , encephalitis , haemoglobin decreased, hyperthermia. Epzicom dosage: unknown. During the same period patient was treated with COMBIVIR, KALETRA, REYATAZ, VALIXA, FOSCAVIR, BAKTAR, DIFLUCAN, ROCEPHIN. Patient was hospitalized. Patient recovered.

Epzicom Side Effects Report #5522197-2
Epzicom side effect was reported by a Physician from JAPAN on Nov 16, 2007. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome, antifungal prophylaxis, syphilis  and was treated with Epzicom. After drug was administered, patient experienced the following side effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder , encephalitis , haemoglobin decreased, hyperthermia. Epzicom dosage: unknown. During the same period patient was treated with COMBIVIR, KALETRA, REYATAZ, VALGANCICLOVIR, FOSCAVIR, BACTRIM, DIFLUCAN, ROCEPHIN. Patient was hospitalized. Patient recovered.

Epzicom Side Effects Report #5600111-9
Epzicom side effect was reported by a Physician from JAPAN on Jan 21, 2008. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome, encephalitis cytomegalovirus, mycobacterium avium complex infection, antifungal prophylaxis and was treated with Epzicom. After drug was administered, patient experienced the following side effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder , encephalitis , haemoglobin decreased, hyperthermia. Epzicom dosage: unknown. During the same period patient was treated with COMBIVIR, KALETRA, REYATAZ, VALGANCICLOVIR, FOSCAVIR, ZITHROMAX, BAKTAR, DIFLUCAN. Patient was hospitalized. Patient recovered.


Epzicom Side Effects Report #5841821-8
Epzicom side effect was reported by a Physician from JAPAN on Aug 08, 2008. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome, mycobacterium avium complex infection, antifungal prophylaxis and was treated with Epzicom. After drug was administered, patient experienced the following side effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder , encephalitis , haemoglobin decreased, hyperthermia. Epzicom dosage: unknown. During the same period patient was treated with COMBIVIR, KALETRA, VALGANCICLOVIR, FOSCAVIR, ZITHROMAX, REYATAZ, COTRIM, DIFLUCAN. Patient was hospitalized. Patient died on 04/14/2007.

Epzicom Side Effects Report #5848193-3
Epzicom side effect was reported by a Physician from JAPAN on Aug 08, 2008. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome, antifungal prophylaxis, syphilis  and was treated with Epzicom. After drug was administered, patient experienced the following side effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder , encephalitis , haemoglobin decreased, hyperthermia. Epzicom dosage: unknown. During the same period patient was treated with COMBIVIR, KALETRA, VALGANCICLOVIR, FOSCAVIR, REYATAZ, COTRIM, DIFLUCAN, ROCEPHIN. Patient was hospitalized. Patient died on 04/14/2007.

Epzicom Side Effects Report #5919367-8
Epzicom side effect was reported by a Physician from JAPAN on Oct 10, 2008. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome, antifungal prophylaxis, syphilis  and was treated with Epzicom. After drug was administered, patient experienced the following side effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder , encephalitis , haemoglobin decreased, hyperthermia. Epzicom dosage: unknown. During the same period patient was treated with COMBIVIR, KALETRA, VALGANCICLOVIR, FOSCAVIR, REYATAZ, COTRIM, DIFLUCAN, ROCEPHIN. Patient was hospitalized. Patient died on 04/14/2007.

Epzicom Side Effects Report #5922044-0
Epzicom side effect was reported by a Physician from JAPAN on Oct 10, 2008. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome, antifungal prophylaxis, syphilis  and was treated with Epzicom. After drug was administered, patient experienced the following side effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder , encephalitis , haemoglobin decreased, hyperthermia. Epzicom dosage: unknown. During the same period patient was treated with COMBIVIR, KALETRA, VALGANCICLOVIR, FOSCAVIR, REYATAZ, COTRIM, DIFLUCAN, ROCEPHIN. Patient was hospitalized. Patient died on 04/14/2007.